These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 8152287

  • 41. Development of zidovudine resistance mutations in patients receiving prolonged didanosine monotherapy.
    Demeter LM, Nawaz T, Morse G, Dolin R, Dexter A, Gerondelis P, Reichman RC.
    J Infect Dis; 1995 Dec; 172(6):1480-5. PubMed ID: 7594706
    [Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. Susceptibility of HIV-1 isolates to zidovudine: correlation between widely applicable culture test and PCR analysis.
    Jung M, Agut H, Candotti D, Ingrand D, Katlama C, Huraux JM.
    J Acquir Immune Defic Syndr (1988); 1992 Dec; 5(4):359-64. PubMed ID: 1372352
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. HIV with reduced sensitivity to zidovudine (AZT) isolated during prolonged therapy.
    Larder BA, Darby G, Richman DD.
    Science; 1989 Mar 31; 243(4899):1731-4. PubMed ID: 2467383
    [Abstract] [Full Text] [Related]

  • 51. Primary infection with zidovudine-resistant human immunodeficiency virus type 1 does not adversely affect outcome at 1 year. Sydney Primary HIV Infection Study Group.
    Imrie A, Carr A, Duncombe C, Finlayson R, Vizzard J, Law M, Kaldor J, Penny R, Cooper DA.
    J Infect Dis; 1996 Jul 31; 174(1):195-8. PubMed ID: 8655994
    [Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. Use of self-sustained sequence replication amplification reaction to analyze and detect mutations in zidovudine-resistant human immunodeficiency virus.
    Gingeras TR, Prodanovich P, Latimer T, Guatelli JC, Richman DD, Barringer KJ.
    J Infect Dis; 1991 Dec 31; 164(6):1066-74. PubMed ID: 1955709
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57. Ordered appearance of zidovudine resistance mutations during treatment of 18 human immunodeficiency virus-positive subjects.
    Boucher CA, O'Sullivan E, Mulder JW, Ramautarsing C, Kellam P, Darby G, Lange JM, Goudsmit J, Larder BA.
    J Infect Dis; 1992 Jan 31; 165(1):105-10. PubMed ID: 1370174
    [Abstract] [Full Text] [Related]

  • 58. Isolation of drug-resistant variants of HIV-1 from patients on long-term zidovudine therapy. Canadian Zidovudine Multi-Centre Study Group.
    Rooke R, Tremblay M, Soudeyns H, DeStephano L, Yao XJ, Fanning M, Montaner JS, O'Shaughnessy M, Gelmon K, Tsoukas C.
    AIDS; 1989 Jul 31; 3(7):411-5. PubMed ID: 2504243
    [Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60. HIV-1 sensitivity to zidovudine: a consensus culture technique validated by genotypic analysis of the reverse transcriptase.
    Brun-Vézinet F, Ingrand D, Deforges L, Gochi K, Ferchal F, Schmitt MP, Jung M, Masquelier B, Aubert J, Buffet-Janvresse C.
    J Virol Methods; 1992 May 31; 37(2):177-88. PubMed ID: 1375948
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.